Natural product anti-inflammatory therapy for upper respiratory tract inflammatory diseases: Eriocitrin, isolated from lemons, increases the expression of negative regulator of inflammation MyD88(s), inhibits pro-inflammatory mediators in lungs, and alleviates the common respiratory pathogen nontypeable Haemophilus influenzae (NTHi)-exacerbated asthma & chronic obstructive pulmonary disease via up-regulation of its target gene, 28/November/2015, 10.45 pm

Molecular therapy for triple-negative breast tumors: BMP4 increases the levels of cell cycle inhibitor, p27, inhibits pro-survival pathways mediated by c-Myc, and inhibits the progression of triple-negative breast cancer via up-regulation of its target gene, 28/November/2015, 7.04 pm
November 28, 2016
Natural product Life-span extension therapy: N(1), N(11)-Diethylnorspermine, a spermine analog, may increase life span by suppressing mTOR pathway, 28/November/2016, 11.13 pm
November 28, 2016
Show all

Introduction: What they say: 

A study from the Center for Inflammation, Immunity & Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA, 30303, USA shows that: “Resveratrol suppresses NTHi-induced inflammation via up-regulation of the negative regulator MyD88 short.” This study was published in the 28 September 2016 issue of the journal “Scientific reports” by Prof. Li JD, Andrews CS and others.


What we say

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Natural product anti-inflammatory therapy for upper respiratory tract inflammatory diseases: Eriocitrin, isolated from lemons,  increases the expression of negative regulator of inflammation MyD88(s), inhibits pro-inflammatory mediators in lungs, and alleviates the common respiratory pathogen nontypeable Haemophilus influenzae (NTHi)-exacerbated asthma & chronic obstructive pulmonary disease via up-regulation of its target gene

price-300[easy_payment currency=”USD”]


From Significance of the study to Public health relevance:

Given that: (1) Pulmonary disease (PD) is a progressive degenerative disease of the lung, with debilitating consequences; (2) drugs that are currently used to treat inflammatory disease of the upper respiratory tract (URI) are ineffective, especially in aged patients; (3) molecular mechanisms involved in the development of URI inflammatory diseases is poorly understood; (4) Chronic obstructive inflammatory disease (COPD) is the third leading cause of death worldwide; (5) one-half billion people worldwide are affected by Asthma and COPD; (6) approx. 2. 5 lakhs of patients worldwide die of asthma every year; (7) microbes that cause these inflammatory diseases become resistant to conventional antibiotic therapy frequently; and (8) billions of dollars are being spent every year worldwide to treat these diseases, there is an urgent need to find: (i) a way to control abnormal levels of inflammatory mediators found in URI inflammatory disease patients; (ii) non-antibiotic therapeutics; (iii) a side-effect-free natural product-based drug; and (iv) a way to effectively treat and cure URI inflammatory disease.


What is known 

Prof. Li’s research team has recently shown that Resveratrol, by increasing the negative regulator of inflammation MyD88(s), it suppresses NTH-1-exacerbated inflammation.


From Research Findings to Therapeutic opportunity

This study suggests, for the first time, that Eriocitrin, by increasing the expression of its target gene, it may: (1) increase the expression of MKP/DUSP1; (2) decrease the phosphorylation and the activity of ERK1/2; (3) increase the expression of the negative regulator of inflammation MyD88-short. Thereby, it may inhibit: (1) respiratory pathogen NTHi-aggravated inflammation and its mediators such as IL-1β, IL-6, CCL-2 and GM-CSF; (2) lung inflammation; and (3) the progression of upper respiratory tract inflammatory diseases such as Asthma and Chronic obstructive inflammatory disease.

Lemon tree

Lemon tree

Figure 1. Pueraria-lobata. Eriocitrin, found in lemons, inhibits human cancer cell proliferation via down-regulation of Tripeptidyl Peptidase 1 (TPP1) and telomerase

Figure 1. Lemon fruits. Eriocitrin, isolated from  lemons, inhibits the progression of NDHi-aggravated inflammation via up-regulation of MKP/Dusp-1 and MyD88 (Short)

Image result for Eriocitrin

Eriocitrin

Thus, pharmacological formulations encompassing Eriocitrin or its analogues or Eriocitrin plus any known anti-inflammatory compound in use may be used to control inflammatory mediators in upper respiratory tract inflammatory diseases.


Details of the research findings:

Idea Proposed/Formulated by: Dr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Undisclosed information: How  Eriocitrin increases the expression of MyD88 (Short).

Amount: $300#

For payment and purchase details, you may reach us at admin@genomediscovery.org

# Research cooperation


References

Web: http://genomediscovery.org org or http://newbioideas.com

To cite: Boominathan, L., Natural product anti-inflammatory therapy for upper respiratory tract inflammatory diseases: Eriocitrin, isolated from lemons,  increases the expression of negative regulator of inflammation MyD88(s), inhibits pro-inflammatory mediators in lungs, and alleviates the common respiratory pathogen nontypeable Haemophilus influenzae (NTHi)-exacerbated asthma & chronic obstructive pulmonary disease via up-regulation of its target gene, 28/November/2015, 10.45 pm, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite us, kindly drop us a mail at info@genomediscovery.org

 

Comments are closed.